BioNTech (United States)

BioNTech (United States)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (United States), United States, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

68%


Total
Publications

120


Total Open
Publications

82


Total
Citations

4.3K


Open Access
Percentage

68%


Total
Publications

120


Total Open
Publications

82


Total
Citations

4.3K

Wikipedia

Website

download

Breakdown

29% 27% 2% 42%

Publisher Open

29%

Both

27%

Other Platform Open

2%

Closed

42%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224262830Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

35%OA Journal

OA Journal 35%

18

Hybrid 45%

23

No Guarantees 20%

10

Other Platform Open

Domain 79%

23

Other Internet 17%

5

Institution 3%

1

Public 3%

1

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
23
DOI
Other Internet
5
Max Planck Society - MPG.PuRe
Institution
1
Figshare
Public
1
1 / 1

Data updated 18 August 2025

Share

Share

Share